Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 2
R&D Momentum
69/100
Pipeline Velocity
41/100
Trial Completion Rate
52/100
Pipeline Concentration
44/100
Pipeline Freshness
62/100
Strategic Signals
Activity
Last 14 days
Transcutaneous Vagus Nerve Stimulation in SLE (TvSSLE)
Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression
Risk Stratification for Asymptomatic Women With Incidentally Found Breast Artery Calcification on Their Routine Screening Mammogram
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)